Hbk Investments L P Exelixis, Inc. Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $2.09 Million - $2.64 Million	-106,700 Reduced 42.51%	144,300 $3.43 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $5.11 Million - $7.35 Million	230,603 Added 1130.57%	251,000 $5.56 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $494,219 - $630,879	20,397	20,397 $620,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.